{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:40:28Z","timestamp":1755222028793,"version":"3.43.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,9]]},"DOI":"10.7759\/cureus.89682","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T12:33:07Z","timestamp":1754742787000},"source":"Crossref","is-referenced-by-count":0,"title":["Prospective Assessment of Alzheimer's Disease-Like Hypometabolism Pattern in the Brain of Diabetics in Contrast to Non-diabetics on Positron Emission Tomography-Computed Tomography Images Using Fluorodeoxyglucose in India"],"prefix":"10.7759","author":[{"given":"Pankaj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram R","family":"Lele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Jawed","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1573399819666230413094200","article-title":"Prevalence of diabetes in India: a review of IDF Diabetes Atlas 10th edition","volume":"20","author":"Kumar A","year":"2024","unstructured":"Kumar A, Gangwar R, Zargar AA, Kumar R, Sharma A. Prevalence of diabetes in India: a review of IDF Diabetes Atlas 10th edition. Curr Diabetes Rev. 2024, 20:e130423215752. 10.2174\/1573399819666230413094200","journal-title":"Curr Diabetes Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India","volume":"69","author":"Pradeepa R","year":"2021","unstructured":"Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021, 69:2932-8. 10.4103\/ijo.IJO_1627_21","journal-title":"Indian J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1549","article-title":"Insulin resistance is associated with enhanced brain glucose uptake during euglycemic hyperinsulinemia: a large-scale PET cohort","volume":"44","author":"Rebelos E","year":"2021","unstructured":"Rebelos E, Bucci M, Karjalainen T, et al.. Insulin resistance is associated with enhanced brain glucose uptake during euglycemic hyperinsulinemia: a large-scale PET cohort. Diabetes Care. 2021, 44:788-94. 10.2337\/dc20-1549","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040874","article-title":"Insulin resistance and oxidative stress in the brain: what's new?","volume":"20","author":"Maciejczyk M","year":"2019","unstructured":"Maciejczyk M, \u017bebrowska E, Chabowski A. Insulin resistance and oxidative stress in the brain: what's new?. Int J Mol Sci. 2019, 20:874. 10.3390\/ijms20040874","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson J","year":"2004","unstructured":"Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004, 53:474-81. 10.2337\/diabetes.53.2.474","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure MA","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019, 14:32. 10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6219","article-title":"Regional cerebral blood flow in the posterior cingulate and precuneus and the Entorhinal Cortical Atrophy Score differentiate mild cognitive impairment and dementia due to Alzheimer disease","volume":"40","author":"Thomas B","year":"2019","unstructured":"Thomas B, Sheelakumari R, Kannath S, Sarma S, Menon RN. Regional cerebral blood flow in the posterior cingulate and precuneus and the Entorhinal Cortical Atrophy Score differentiate mild cognitive impairment and dementia due to Alzheimer disease. AJNR Am J Neuroradiol. 2019, 40:1658-64. 10.3174\/ajnr.A6219","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3695","article-title":"PET approaches for diagnosis of dementia","volume":"35","author":"Ishii K","year":"2014","unstructured":"Ishii K. PET approaches for diagnosis of dementia. AJNR Am J Neuroradiol. 2014, 35:2030-8. 10.3174\/ajnr.A3695","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease","volume":"36","author":"Mosconi L","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R, et al.. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2009, 36:811-22. 10.1007\/s00259-008-1039-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte SM","year":"2008","unstructured":"de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol. 2008, 2:1101-13. 10.1177\/193229680800200619","journal-title":"J Diabetes Sci Technol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3233\/jad-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?","volume":"7","author":"Steen E","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, et al.. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?. J Alzheimers Dis. 2005, 7:63-80. 10.3233\/jad-2005-7107","journal-title":"J Alzheimers Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102383","article-title":"True or false? Alzheimer's disease is type 3 diabetes: evidences from bench to bedside","volume":"99","author":"Peng Y","year":"2024","unstructured":"Peng Y, Yao SY, Chen Q, Jin H, Du MQ, Xue YH, Liu S. True or false? Alzheimer's disease is type 3 diabetes: evidences from bench to bedside. Ageing Res Rev. 2024, 99:102383. 10.1016\/j.arr.2024.102383","journal-title":"Ageing Res Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker LD","year":"2011","unstructured":"Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol. 2011, 68:51-7. 10.1001\/archneurol.2010.225","journal-title":"Arch Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.11.1551","article-title":"Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study","volume":"63","author":"Akomolafe A","year":"2006","unstructured":"Akomolafe A, Beiser A, Meigs JB, et al.. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol. 2006, 63:1551-5. 10.1001\/archneur.63.11.1551","journal-title":"Arch Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: breaking the memory barrier","volume":"101","author":"Kamatham PT","year":"2024","unstructured":"Kamatham PT, Shukla R, Khatri DK, Vora LK. Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: breaking the memory barrier. Ageing Res Rev. 2024, 101:102481. 10.1016\/j.arr.2024.102481","journal-title":"Ageing Res Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse G","year":"2015","unstructured":"Bedse G, Di Domenico F, Serviddio G, Cassano T. Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front Neurosci. 2015, 9:204. 10.3389\/fnins.2015.00204","journal-title":"Front Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01090-x","article-title":"Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease","volume":"31","author":"Hong CT","year":"2024","unstructured":"Hong CT, Chen JH, Hu CJ. Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease. J Biomed Sci. 2024, 31:102. 10.1186\/s12929-024-01090-x","journal-title":"J Biomed Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1322118","article-title":"The utility of PET imaging in depression","volume":"15","author":"Singh SB","year":"2024","unstructured":"Singh SB, Tiwari A, Katta MR, et al.. The utility of PET imaging in depression. Front Psychiatry. 2024, 15:1322118. 10.3389\/fpsyt.2024.1322118","journal-title":"Front Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01346-4","article-title":"The relationship between diabetes and the dementia risk: a meta-analysis","volume":"16","author":"Cao F","year":"2024","unstructured":"Cao F, Yang F, Li J, et al.. The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr. 2024, 16:101. 10.1186\/s13098-024-01346-4","journal-title":"Diabetol Metab Syndr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2019.12.028","article-title":"Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators","volume":"27","author":"Jayaraj RL","year":"2020","unstructured":"Jayaraj RL, Azimullah S, Beiram R. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators. Saudi J Biol Sci. 2020, 27:736-50. 10.1016\/j.sjbs.2019.12.028","journal-title":"Saudi J Biol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1017\/s104161020200844x","article-title":"Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old","volume":"14","author":"Hassing LB","year":"2002","unstructured":"Hassing LB, Johansson B, Nilsson SE, Berg S, Pedersen NL, Gatz M, McClearn G. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int Psychogeriatr. 2002, 14:239-48. 10.1017\/s104161020200844x","journal-title":"Int Psychogeriatr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.52.5.971","article-title":"Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance","volume":"52","author":"Curb JD","year":"1999","unstructured":"Curb JD, Rodriguez BL, Abbott RD, et al.. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 1999, 52:971-5. 10.1212\/wnl.52.5.971","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging","volume":"70","author":"Thambisetty M","year":"2013","unstructured":"Thambisetty M, Metter EJ, Yang A, et al.. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol. 2013, 70:1167-72. 10.1001\/jamaneurol.2013.284","journal-title":"JAMA Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000064928","article-title":"Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging","volume":"14","author":"MacKnight C","year":"2002","unstructured":"MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord. 2002, 14:77-83. 10.1159\/000064928","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.5.1306","article-title":"Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study","volume":"49","author":"Heitner J","year":"1997","unstructured":"Heitner J, Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology. 1997, 49:1306-11. 10.1212\/wnl.49.5.1306","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000247053.45483.4e","article-title":"Diabetes is related to cerebral infarction but not to AD pathology in older persons","volume":"67","author":"Arvanitakis Z","year":"2006","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006, 67:1960-5. 10.1212\/01.wnl.0000247053.45483.4e","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.132647","article-title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","volume":"55","author":"Roberts RO","year":"2014","unstructured":"Roberts RO, Knopman DS, Cha RH, et al.. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med. 2014, 55:759-64. 10.2967\/jnumed.113.132647","journal-title":"J Nucl Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170179","article-title":"Diabetes is not associated with Alzheimer's disease neuropathology","volume":"60","author":"Dos Santos Matioli MN","year":"2017","unstructured":"Dos Santos Matioli MN, Suemoto CK, Rodriguez RD, et al.. Diabetes is not associated with Alzheimer's disease neuropathology. J Alzheimers Dis. 2017, 60:1035-43. 10.3233\/JAD-170179","journal-title":"J Alzheimers Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12248","article-title":"Is diabetes associated with increased pathological burden in Alzheimer's disease?","volume":"13","author":"Sadrolashrafi K","year":"2021","unstructured":"Sadrolashrafi K, Craft S, Decourt B, Adem A, Wilson JR, Miller J, Sabbagh MN. Is diabetes associated with increased pathological burden in Alzheimer's disease?. Alzheimers Dement (Amst). 2021, 13:e12248. 10.1002\/dad2.12248","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer's disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies","volume":"24","author":"Pires M","year":"2023","unstructured":"Pires M, Rego AC. Apoe4 and Alzheimer's disease pathogenesis-mitochondrial deregulation and targeted therapeutic strategies. Int J Mol Sci. 2023, 24:778. 10.3390\/ijms24010778","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.150045","article-title":"Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers","volume":"56","author":"Ishibashi K","year":"2015","unstructured":"Ishibashi K, Onishi A, Fujiwara Y, Ishiwata K, Ishii K. Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers. J Nucl Med. 2015, 56:229-33. 10.2967\/jnumed.114.150045","journal-title":"J Nucl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386247-prospective-assessment-of-alzheimers-disease-like-hypometabolism-pattern-in-the-brain-of-diabetics-in-contrast-to-non-diabetics-on-positron-emission-tomography-computed-tomography-images-using-fluorodeoxyglucose-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T12:33:08Z","timestamp":1754742788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386247-prospective-assessment-of-alzheimers-disease-like-hypometabolism-pattern-in-the-brain-of-diabetics-in-contrast-to-non-diabetics-on-positron-emission-tomography-computed-tomography-images-using-fluorodeoxyglucose-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.89682","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,9]]}}}